Paul M. Kent, MD, is an assistant professor of pediatrics and attending physician in pediatric hematology/oncology at Rush University Medical Center. Kent received a Bachelor of Arts degree from HarvardUniversity in 1987. He earned his doctorate in medicine from MayoClinicMedicalSchool in 1994. Kent completed his internship training at the Mayo Clinic in Rochester, Minn. (1994), and residency training in pediatrics (1995-1996) at the University of Chicago, where he was chosen for the Alpha Omega Alpha (AOA) medical honor society. Kent served as the pediatric chief resident at the University of Chicago in 1998. He was fellowship trained in hematology and oncology (1998–2001) at Children's MemorialHospital in Chicago. He was board-certified in pediatrics in 1997 and sub-board-certified in pediatric hematology and oncology in 2002. Kent has won numerous awards for teaching and patient care throughout his career. He is the founder of the Rush Sarcoma Tumor Conference, which evaluates more sarcoma patients than any such group in the Midwest (more than 200 each year). Kent is principal investigator in an ongoing study investigating neonatal infection and correlates with cord blood DNA. He has lectured extensively on cord blood donation and research as well as sickle cell anemia and all types of pediatric cancer. He has published work in bleeding disorders as well as blood and cancer in children.